-
From Breakthrough to Blockbuster
- The Business of Biotechnology
- Narrated by: Chris Andrew Ciulla
- Length: 7 hrs and 1 min
Failed to add items
Add to Cart failed.
Add to Wish List failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
From Breakthrough to Blockbuster
Buy for $17.19
No default payment method selected.
We are sorry. We are not allowed to sell this product with the selected payment method
Listeners also enjoyed...
-
The Drug Discovery and Development Cycle
- A Concise Overview of the Key Steps from Concept to Launch
- By: Kabir Hussain
- Narrated by: Rebecca Sharp
- Length: 1 hr and 31 mins
- Unabridged
-
Overall4.5 out of 5 stars 16
-
Performance5 out of 5 stars 12
-
Story4.5 out of 5 stars 11
The pharmaceutical drug discovery and development cycle is long and complex. This audiobook provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development.
By: Kabir Hussain
-
The Billion Dollar Molecule
- One Company's Quest for the Perfect Drug
- By: Barry Werth
- Narrated by: Stephen Bowlby
- Length: 18 hrs and 25 mins
- Unabridged
-
Overall4.5 out of 5 stars 24
-
Performance4 out of 5 stars 20
-
Story4 out of 5 stars 20
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.
-
4 out of 5 stars
-
Book is interesting but narrator is not
- By Anonymous User on 05-05-23
By: Barry Werth
-
Bottle of Lies
- The Inside Story of the Generic Drug Boom
- By: Katherine Eban
- Narrated by: Katherine Eban
- Length: 14 hrs and 26 mins
- Unabridged
-
Overall5 out of 5 stars 1,054
-
Performance4.5 out of 5 stars 924
-
Story5 out of 5 stars 922
From an award-winning Fortune reporter, an explosive narrative investigation of the generic drug boom that reveals the life-threatening dangers posed by globalization - The Jungle for pharmaceuticals.
-
1 out of 5 stars
-
overbearing self-righteous indignation
- By VB on 01-13-20
By: Katherine Eban
-
For Blood and Money
- Billionaires, Biotech, and the Quest for a Blockbuster Drug
- By: Nathan Vardi
- Narrated by: Rob Shapiro
- Length: 8 hrs and 33 mins
- Unabridged
-
Overall4.5 out of 5 stars 184
-
Performance4.5 out of 5 stars 155
-
Story4.5 out of 5 stars 154
For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug and how the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.
-
5 out of 5 stars
-
Must-read for biotech enthusiasts and scientists
- By Anonymous User on 03-16-23
By: Nathan Vardi
-
Inside the Orphan Drug Revolution
- The Promise of Patient-Centered Biotechnology
- By: James A. Geraghty
- Narrated by: Scott Wallace
- Length: 7 hrs and 39 mins
- Unabridged
-
Overall4.5 out of 5 stars 5
-
Performance5 out of 5 stars 4
-
Story5 out of 5 stars 4
Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception―a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. His book is in part a history, with eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. And it tells deeply personal stories of patients and parents willing to risk untried new therapies.
-
5 out of 5 stars
-
powerful and insightful
- By Colin G. on 06-01-23
-
Elon Musk
- By: Walter Isaacson
- Narrated by: Jeremy Bobb, Walter Isaacson
- Length: 20 hrs and 39 mins
- Unabridged
-
Overall5 out of 5 stars 6,507
-
Performance5 out of 5 stars 5,786
-
Story5 out of 5 stars 5,780
When Elon Musk was a kid in South Africa, he was regularly beaten by bullies. One day a group pushed him down some concrete steps and kicked him until his face was a swollen ball of flesh. He was in the hospital for a week. But the physical scars were minor compared to the emotional ones inflicted by his father, an engineer, rogue, and charismatic fantasist.
-
4 out of 5 stars
-
megalomania on display
- By JP on 09-12-23
By: Walter Isaacson
-
The Drug Discovery and Development Cycle
- A Concise Overview of the Key Steps from Concept to Launch
- By: Kabir Hussain
- Narrated by: Rebecca Sharp
- Length: 1 hr and 31 mins
- Unabridged
-
Overall4.5 out of 5 stars 16
-
Performance5 out of 5 stars 12
-
Story4.5 out of 5 stars 11
The pharmaceutical drug discovery and development cycle is long and complex. This audiobook provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development.
By: Kabir Hussain
-
The Billion Dollar Molecule
- One Company's Quest for the Perfect Drug
- By: Barry Werth
- Narrated by: Stephen Bowlby
- Length: 18 hrs and 25 mins
- Unabridged
-
Overall4.5 out of 5 stars 24
-
Performance4 out of 5 stars 20
-
Story4 out of 5 stars 20
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.
-
4 out of 5 stars
-
Book is interesting but narrator is not
- By Anonymous User on 05-05-23
By: Barry Werth
-
Bottle of Lies
- The Inside Story of the Generic Drug Boom
- By: Katherine Eban
- Narrated by: Katherine Eban
- Length: 14 hrs and 26 mins
- Unabridged
-
Overall5 out of 5 stars 1,054
-
Performance4.5 out of 5 stars 924
-
Story5 out of 5 stars 922
From an award-winning Fortune reporter, an explosive narrative investigation of the generic drug boom that reveals the life-threatening dangers posed by globalization - The Jungle for pharmaceuticals.
-
1 out of 5 stars
-
overbearing self-righteous indignation
- By VB on 01-13-20
By: Katherine Eban
-
For Blood and Money
- Billionaires, Biotech, and the Quest for a Blockbuster Drug
- By: Nathan Vardi
- Narrated by: Rob Shapiro
- Length: 8 hrs and 33 mins
- Unabridged
-
Overall4.5 out of 5 stars 184
-
Performance4.5 out of 5 stars 155
-
Story4.5 out of 5 stars 154
For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug and how the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.
-
5 out of 5 stars
-
Must-read for biotech enthusiasts and scientists
- By Anonymous User on 03-16-23
By: Nathan Vardi
-
Inside the Orphan Drug Revolution
- The Promise of Patient-Centered Biotechnology
- By: James A. Geraghty
- Narrated by: Scott Wallace
- Length: 7 hrs and 39 mins
- Unabridged
-
Overall4.5 out of 5 stars 5
-
Performance5 out of 5 stars 4
-
Story5 out of 5 stars 4
Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception―a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. His book is in part a history, with eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. And it tells deeply personal stories of patients and parents willing to risk untried new therapies.
-
5 out of 5 stars
-
powerful and insightful
- By Colin G. on 06-01-23
-
Elon Musk
- By: Walter Isaacson
- Narrated by: Jeremy Bobb, Walter Isaacson
- Length: 20 hrs and 39 mins
- Unabridged
-
Overall5 out of 5 stars 6,507
-
Performance5 out of 5 stars 5,786
-
Story5 out of 5 stars 5,780
When Elon Musk was a kid in South Africa, he was regularly beaten by bullies. One day a group pushed him down some concrete steps and kicked him until his face was a swollen ball of flesh. He was in the hospital for a week. But the physical scars were minor compared to the emotional ones inflicted by his father, an engineer, rogue, and charismatic fantasist.
-
4 out of 5 stars
-
megalomania on display
- By JP on 09-12-23
By: Walter Isaacson
-
The Song of the Cell
- An Exploration of Medicine and the New Human
- By: Siddhartha Mukherjee
- Narrated by: Dennis Boutsikaris
- Length: 16 hrs and 3 mins
- Unabridged
-
Overall4.5 out of 5 stars 777
-
Performance5 out of 5 stars 659
-
Story4.5 out of 5 stars 653
From the author of The Emperor of All Maladies, winner of the Pulitzer Prize, and The Gene, a #1 New York Times bestseller, comes his most spectacular book yet, an exploration of medicine and our radical new ability to manipulate cells. Rich with Mukherjee’s revelatory and exhilarating stories of scientists, doctors, and the patients whose lives may be saved by their work, The Song of the Cell is the third book in this extraordinary writer’s exploration of what it means to be human.
-
5 out of 5 stars
-
Beyond Words Wonderful
- By Lynn on 11-27-22
-
Immune
- A Journey into the Mysterious System That Keeps You Alive
- By: Philipp Dettmer
- Narrated by: Steve Taylor
- Length: 10 hrs and 28 mins
- Unabridged
-
Overall5 out of 5 stars 1,175
-
Performance5 out of 5 stars 1,008
-
Story5 out of 5 stars 1,001
You wake up and feel a tickle in your throat. Your head hurts. You’re mildly annoyed as you get the kids ready for school and dress for work yourself. Meanwhile, an epic war is being fought, just below your skin. Millions are fighting and dying for you to be able to complain as you head out the door. So what, exactly, is your immune system? In Immune, Philipp Dettmer, the brains behind the most popular science channel on YouTube, takes listeners on a journey through the fortress of the human body and its defenses.
-
5 out of 5 stars
-
Steve Taylor for the win
- By Bay Area Engineer on 11-02-21
By: Philipp Dettmer
-
Ten Drugs
- How Plants, Powders, and Pills Have Shaped the History of Medicine
- By: Thomas Hager
- Narrated by: Angelo Di Loreto
- Length: 8 hrs and 39 mins
- Unabridged
-
Overall4.5 out of 5 stars 4,852
-
Performance4.5 out of 5 stars 4,199
-
Story4.5 out of 5 stars 4,181
Beginning with opium, the “joy plant,” which has been used for 10,000 years, Thomas Hager tells a captivating story of medicine. His subjects include the largely forgotten female pioneer who introduced smallpox inoculation to Britain, the infamous knockout drops, the first antibiotic, which saved countless lives, the first antipsychotic, which helped empty public mental hospitals, Viagra, statins, and the new frontier of monoclonal antibodies. This is a deep, wide-ranging, and wildly entertaining book.
-
4 out of 5 stars
-
Engrossing to physicians & lay persons alike
- By C. White on 03-08-19
By: Thomas Hager
-
Outlive
- The Science and Art of Longevity
- By: Peter Attia MD, Bill Gifford - contributor
- Narrated by: Peter Attia MD
- Length: 17 hrs and 7 mins
- Unabridged
-
Overall5 out of 5 stars 5,188
-
Performance5 out of 5 stars 4,555
-
Story5 out of 5 stars 4,544
Wouldn’t you like to live longer? And better? In this operating manual for longevity, Dr. Peter Attia draws on the latest science to deliver innovative nutritional interventions, techniques for optimizing exercise and sleep, and tools for addressing emotional and mental health.
-
2 out of 5 stars
-
Too Much Filler
- By J. Badaracco on 04-09-23
By: Peter Attia MD, and others
-
The Antidote
- Inside the World of New Pharma
- By: Barry Werth
- Narrated by: Sean Pratt
- Length: 16 hrs and 27 mins
- Unabridged
-
Overall4 out of 5 stars 75
-
Performance4 out of 5 stars 64
-
Story4 out of 5 stars 65
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex's bold endurance and eventual success.
-
2 out of 5 stars
-
For me this was not interesting
- By Yan on 06-26-17
By: Barry Werth
-
The Emperor of All Maladies
- A Biography of Cancer
- By: Siddhartha Mukherjee
- Narrated by: Fred Sanders
- Length: 22 hrs and 18 mins
- Unabridged
-
Overall5 out of 5 stars 4,615
-
Performance5 out of 5 stars 4,049
-
Story5 out of 5 stars 4,027
The Emperor of All Maladies reveals the many faces of an iconic, shape-shifting disease that is the defining plague of our generation. The story of cancer is a story of human ingenuity, resilience, and perseverance but also of hubris, arrogance, paternalism, and misperception, all leveraged against a disease that, just three decades ago, was thought to be easily vanquished in an all-out "war against cancer".
-
5 out of 5 stars
-
Incredible
- By S.R.E. on 03-02-16
-
Regenesis
- How Synthetic Biology Will Reinvent Nature and Ourselves
- By: George M. Church, Ed Regis
- Narrated by: Peter Lerman
- Length: 10 hrs and 47 mins
- Unabridged
-
Overall4.5 out of 5 stars 72
-
Performance4 out of 5 stars 59
-
Story4.5 out of 5 stars 59
In Regenesis, George Church and science writer Ed Regis explore the possibilities of the emerging field of synthetic biology. Synthetic biology, in which living organisms are selectively altered by modifying substantial portions of their genomes, allows for the creation of entirely new species of organisms. These technologies - far from the out-of-control nightmare depicted in science fiction - have the power to improve human and animal health, increase our intelligence, enhance our memory, and even extend our life span.
-
5 out of 5 stars
-
Brilliant! But please update!
- By Nick on 01-28-21
By: George M. Church, and others
-
Chip War
- The Quest to Dominate the World's Most Critical Technology
- By: Chris Miller
- Narrated by: Stephen Graybill
- Length: 12 hrs and 38 mins
- Unabridged
-
Overall5 out of 5 stars 1,920
-
Performance4.5 out of 5 stars 1,631
-
Story5 out of 5 stars 1,629
You may be surprised to learn that microchips are the new oil—the scarce resource on which the modern world depends. Today, military, economic, and geopolitical power are built on a foundation of computer chips. Virtually everything—from missiles to microwaves—runs on chips, including cars, smartphones, the stock market, even the electric grid. Until recently, America designed and built the fastest chips and maintained its lead as the #1 superpower, but America’s edge is in danger of slipping, undermined by players in Taiwan, Korea, and Europe taking over manufacturing.
-
5 out of 5 stars
-
Great history, but could poor narration
- By Lily Wong on 10-26-22
By: Chris Miller
-
The Code Breaker
- Jennifer Doudna, Gene Editing, and the Future of the Human Race
- By: Walter Isaacson
- Narrated by: Kathe Mazur, Walter Isaacson
- Length: 16 hrs and 4 mins
- Unabridged
-
Overall4.5 out of 5 stars 6,190
-
Performance4.5 out of 5 stars 5,250
-
Story4.5 out of 5 stars 5,217
The bestselling author of Leonardo da Vinci and Steve Jobs returns with a “compelling” (The Washington Post) account of how Nobel Prize winner Jennifer Doudna and her colleagues launched a revolution that will allow us to cure diseases, fend off viruses, and have healthier babies.
-
4 out of 5 stars
-
Except for the author, this book is good!
- By Johan on 03-14-21
By: Walter Isaacson
-
The Gene
- An Intimate History
- By: Siddhartha Mukherjee
- Narrated by: Dennis Boutsikaris
- Length: 19 hrs and 22 mins
- Unabridged
-
Overall4.5 out of 5 stars 5,860
-
Performance4.5 out of 5 stars 5,145
-
Story4.5 out of 5 stars 5,098
The extraordinary Siddhartha Mukherjee has written a biography of the gene as deft, brilliant, and illuminating as his extraordinarily successful biography of cancer. Weaving science, social history, and personal narrative to tell us the story of one of the most important conceptual breakthroughs of modern times, Mukherjee animates the quest to understand human heredity and its surprising influence on our lives, personalities, identities, fates, and choices.
-
5 out of 5 stars
-
It's a Wonderful Book
- By JKC on 06-02-16
-
The Great American Drug Deal
- A New Prescription for Innovative and Affordable Medicines
- By: Peter Kolchinsky
- Narrated by: Sean Pratt
- Length: 8 hrs and 27 mins
- Unabridged
-
Overall4.5 out of 5 stars 32
-
Performance4.5 out of 5 stars 24
-
Story4.5 out of 5 stars 24
Developing life-changing drugs is risky and expensive, but that’s not what makes them unaffordable. Drug pricing is a staple of every news cycle and political debate. And while we’ve struggled for decades to agree on solutions that serve all patients without jeopardizing the invention of new medicines, many Americans suffer because they can’t afford the drugs they need. Do we really have to choose between affordability and innovation?
By: Peter Kolchinsky
-
Genentech
- The Beginnings of Biotech
- By: Sally Smith Hughes
- Narrated by: Suzie Althens
- Length: 7 hrs and 12 mins
- Unabridged
-
Overall4 out of 5 stars 32
-
Performance4 out of 5 stars 25
-
Story4.5 out of 5 stars 25
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.
-
2 out of 5 stars
-
Shallow and lifeless
- By LTS on 11-26-23
Publisher's summary
Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources.
Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs.
From Breakthrough to Blockbuster focuses on both the companies themselves and the broader biotech ecosystem that supports them. It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.
More from the same
Related to this topic
-
Jump-Starting America
- How Breakthrough Science Can Revive Economic Growth and the American Dream
- By: Jonathan Gruber, Simon Johnson
- Narrated by: Robert Fass
- Length: 9 hrs and 57 mins
- Unabridged
-
Overall4.5 out of 5 stars 76
-
Performance5 out of 5 stars 59
-
Story4.5 out of 5 stars 59
The untold story of how America once created the most successful economy the world has ever seen and how we can do it again.
By: Jonathan Gruber, and others
-
Angel Investing
- The Gust Guide to Making Money and Having Fun Investing in Startups
- By: David S. Rose
- Narrated by: David S. Rose
- Length: 6 hrs and 42 mins
- Unabridged
-
Overall4.5 out of 5 stars 176
-
Performance4.5 out of 5 stars 146
-
Story4.5 out of 5 stars 143
From building your reputation as a smart investor, to negotiating fair deals, adding value to your portfolio companies and helping them implement smart exit strategies, David provides both the fundamental strategies and the specific tools you need to take full advantage of this rapidly growing asset class.
-
5 out of 5 stars
-
Very enlightening
- By Keith L. on 04-06-15
By: David S. Rose
-
The Entrepreneurial State
- Debunking Public vs. Private Sector Myths
- By: Mariana Mazzucato
- Narrated by: Callie Beaulieu
- Length: 9 hrs and 33 mins
- Unabridged
-
Overall4.5 out of 5 stars 93
-
Performance4.5 out of 5 stars 74
-
Story4.5 out of 5 stars 73
In this sharp and controversial international best seller, an award-winning economist debunks the pervasive myth that the government is sluggish and inept, and at odds with a dynamic private sector. She reveals in detailed case studies that the opposite is true: The state is, and has been, our boldest and most valuable innovator. Denying this history is leading us down the wrong path. A select few get credit for what is an intensely collective effort, and the US government has started disinvesting from innovation.
-
1 out of 5 stars
-
Grossly Propogandist
- By Anonymous User on 03-26-21
-
The Founder's Dilemmas
- By: Noam Wasserman
- Narrated by: Mark Mosely
- Length: 13 hrs and 28 mins
- Unabridged
-
Overall4.5 out of 5 stars 721
-
Performance4.5 out of 5 stars 579
-
Story4 out of 5 stars 571
Often downplayed in the excitement of starting up a new business venture is one of the most important decisions entrepreneurs will face: should they go it alone, or bring in cofounders, hires, and investors to help build the business? More than just financial rewards are at stake. Friendships and relationships can suffer. Bad decisions at the inception of a promising venture lay the foundations for its eventual ruin.
-
2 out of 5 stars
-
Too much talk on the data
- By Stanley Tan on 10-02-14
By: Noam Wasserman
-
The Lords of Strategy
- The Secret Intellectual History of the New Corporate World
- By: Walter Kiechel III
- Narrated by: Robertson Dean
- Length: 11 hrs and 46 mins
- Unabridged
-
Overall4.5 out of 5 stars 399
-
Performance4.5 out of 5 stars 283
-
Story4.5 out of 5 stars 285
Imagine running a business without a strategy. It would be akin to driving blindfolded, to building a house without a blueprint. The concept of strategy changed all that, paving the way for the creation of the modern corporate world. The Lords of Strategy provides listeners with a deeper understanding of the world they compete in, and a sharper eye for what works — and what doesn’t — when forging strategy.
-
5 out of 5 stars
-
Super Book of Narrow Interest
- By Roy on 08-23-10
-
Attacker's Advantage
- Turning Uncertainty into Breakthrough Opportunities
- By: Ram Charan
- Narrated by: Mark Bramhall
- Length: 6 hrs and 8 mins
- Unabridged
-
Overall4 out of 5 stars 80
-
Performance4 out of 5 stars 65
-
Story4 out of 5 stars 66
In The Attacker's Advantage, Charan reveals the upside of uncertainty for those leaders who are nimbly positioned to anticipate the catalysts of disruption and embrace change. He updates and adapts the principles of his previous best sellers to address the current turbulent business environment, cutting through the veil of complexity to concentrate on the new customer needs and expectations and providing the tools for corporate leaders to take their companies to a higher level.
-
4 out of 5 stars
-
Fantastic book - volume lower than usual
- By James Gajewski on 06-14-15
By: Ram Charan
-
Jump-Starting America
- How Breakthrough Science Can Revive Economic Growth and the American Dream
- By: Jonathan Gruber, Simon Johnson
- Narrated by: Robert Fass
- Length: 9 hrs and 57 mins
- Unabridged
-
Overall4.5 out of 5 stars 76
-
Performance5 out of 5 stars 59
-
Story4.5 out of 5 stars 59
The untold story of how America once created the most successful economy the world has ever seen and how we can do it again.
By: Jonathan Gruber, and others
-
Angel Investing
- The Gust Guide to Making Money and Having Fun Investing in Startups
- By: David S. Rose
- Narrated by: David S. Rose
- Length: 6 hrs and 42 mins
- Unabridged
-
Overall4.5 out of 5 stars 176
-
Performance4.5 out of 5 stars 146
-
Story4.5 out of 5 stars 143
From building your reputation as a smart investor, to negotiating fair deals, adding value to your portfolio companies and helping them implement smart exit strategies, David provides both the fundamental strategies and the specific tools you need to take full advantage of this rapidly growing asset class.
-
5 out of 5 stars
-
Very enlightening
- By Keith L. on 04-06-15
By: David S. Rose
-
The Entrepreneurial State
- Debunking Public vs. Private Sector Myths
- By: Mariana Mazzucato
- Narrated by: Callie Beaulieu
- Length: 9 hrs and 33 mins
- Unabridged
-
Overall4.5 out of 5 stars 93
-
Performance4.5 out of 5 stars 74
-
Story4.5 out of 5 stars 73
In this sharp and controversial international best seller, an award-winning economist debunks the pervasive myth that the government is sluggish and inept, and at odds with a dynamic private sector. She reveals in detailed case studies that the opposite is true: The state is, and has been, our boldest and most valuable innovator. Denying this history is leading us down the wrong path. A select few get credit for what is an intensely collective effort, and the US government has started disinvesting from innovation.
-
1 out of 5 stars
-
Grossly Propogandist
- By Anonymous User on 03-26-21
-
The Founder's Dilemmas
- By: Noam Wasserman
- Narrated by: Mark Mosely
- Length: 13 hrs and 28 mins
- Unabridged
-
Overall4.5 out of 5 stars 721
-
Performance4.5 out of 5 stars 579
-
Story4 out of 5 stars 571
Often downplayed in the excitement of starting up a new business venture is one of the most important decisions entrepreneurs will face: should they go it alone, or bring in cofounders, hires, and investors to help build the business? More than just financial rewards are at stake. Friendships and relationships can suffer. Bad decisions at the inception of a promising venture lay the foundations for its eventual ruin.
-
2 out of 5 stars
-
Too much talk on the data
- By Stanley Tan on 10-02-14
By: Noam Wasserman
-
The Lords of Strategy
- The Secret Intellectual History of the New Corporate World
- By: Walter Kiechel III
- Narrated by: Robertson Dean
- Length: 11 hrs and 46 mins
- Unabridged
-
Overall4.5 out of 5 stars 399
-
Performance4.5 out of 5 stars 283
-
Story4.5 out of 5 stars 285
Imagine running a business without a strategy. It would be akin to driving blindfolded, to building a house without a blueprint. The concept of strategy changed all that, paving the way for the creation of the modern corporate world. The Lords of Strategy provides listeners with a deeper understanding of the world they compete in, and a sharper eye for what works — and what doesn’t — when forging strategy.
-
5 out of 5 stars
-
Super Book of Narrow Interest
- By Roy on 08-23-10
-
Attacker's Advantage
- Turning Uncertainty into Breakthrough Opportunities
- By: Ram Charan
- Narrated by: Mark Bramhall
- Length: 6 hrs and 8 mins
- Unabridged
-
Overall4 out of 5 stars 80
-
Performance4 out of 5 stars 65
-
Story4 out of 5 stars 66
In The Attacker's Advantage, Charan reveals the upside of uncertainty for those leaders who are nimbly positioned to anticipate the catalysts of disruption and embrace change. He updates and adapts the principles of his previous best sellers to address the current turbulent business environment, cutting through the veil of complexity to concentrate on the new customer needs and expectations and providing the tools for corporate leaders to take their companies to a higher level.
-
4 out of 5 stars
-
Fantastic book - volume lower than usual
- By James Gajewski on 06-14-15
By: Ram Charan
-
The Future of the Professions
- How Technology Will Transform the Work of Human Experts
- By: Richard Susskind, Daniel Susskind
- Narrated by: John Lee
- Length: 12 hrs and 39 mins
- Unabridged
-
Overall4 out of 5 stars 272
-
Performance4 out of 5 stars 225
-
Story4 out of 5 stars 224
This book predicts the decline of today's professions and describes the people and systems that will replace them. In an Internet society, according to Richard Susskind and Daniel Susskind, we will neither need nor want doctors, teachers, accountants, architects, the clergy, consultants, lawyers, and many others to work as they did in the 20th century.
-
3 out of 5 stars
-
I Hope It's Not All True
- By John on 05-01-16
By: Richard Susskind, and others
-
Winning with Data
- Transform Your Culture, Empower Your People, and Shape the Future
- By: Tomasz Tunguz, Frank Bien
- Narrated by: James Patrick Cronin
- Length: 5 hrs and 37 mins
- Unabridged
-
Overall4 out of 5 stars 90
-
Performance4.5 out of 5 stars 74
-
Story4 out of 5 stars 73
Winning with Data explores the cultural changes big data brings to business, and shows you how to adapt your organization to leverage data to maximum effect. Authors Tomasz Tunguz and Frank Bien draw on extensive background in big data, business intelligence, and business strategy to provide a blueprint for companies looking to move head-on into the data wave. Instrumentation is discussed in detail, but the core of the change is in the culture.
-
1 out of 5 stars
-
Content marketing
- By Adam Winn on 12-22-16
By: Tomasz Tunguz, and others
-
Out-Innovate
- How Global Entrepreneurs - from Delhi to Detroit - Are Rewriting the Rules of Silicon Valley
- By: Alexandre Lazarow
- Narrated by: Dennis Boutsikaris, Alexandre Lazarow
- Length: 7 hrs and 42 mins
- Unabridged
-
Overall4.5 out of 5 stars 45
-
Performance5 out of 5 stars 33
-
Story4.5 out of 5 stars 34
As venture capitalist Alexandre Lazarow shows in this insightful and instructive book, this Silicon Valley "gospel" is due for a refresh - and it comes from what he calls the "frontier", the growing constellation of startup ecosystems, outside of the Valley and other major economic centers, that now stretches across the globe. The frontier is a truly different world where startups often must cope with political or economic instability and lack of infrastructure, and where there might be little or no access to angel investors, venture capitalists, or experienced employee pools.
-
5 out of 5 stars
-
Great material for SF and Frontier entrepreneurs!
- By Brett Fulmer on 04-15-20
-
More Than You Know
- Finding Financial Wisdom in Unconventional Places
- By: Michael J. Mauboussin
- Narrated by: Sean Runnette
- Length: 7 hrs and 27 mins
- Unabridged
-
Overall4.5 out of 5 stars 207
-
Performance4.5 out of 5 stars 178
-
Story4.5 out of 5 stars 176
Since its first publication, Michael J. Mauboussin's popular guide to wise investing has been translated into eight languages and has been named best business book by BusinessWeek and best economics book by Strategy+Business. Now updated to reflect current research and expanded to include new chapters on investment philosophy, psychology, and strategy and science as they pertain to money management.
-
1 out of 5 stars
-
Liked it better when it was written by Taleb
- By Ian on 11-24-18
-
Lead and Disrupt
- How to Solve the Innovator's Dilemma
- By: Charles A. O'Reilly III, Michael L. Tushman
- Narrated by: James Foster
- Length: 8 hrs and 36 mins
- Unabridged
-
Overall4.5 out of 5 stars 148
-
Performance4.5 out of 5 stars 121
-
Story4.5 out of 5 stars 116
In the past few years, a number of well-known firms have failed; think of Blockbuster, Kodak, or RadioShack. When we hear about their demise, it often seems inevitable - a natural part of "creative destruction." But closer examination reveals a disturbing truth: Companies large and small are shuttering more quickly than ever. What does it take to buck this trend? The simple answer is: ambidexterity. Firms must remain competitive in their core markets, while also winning in new domains.
-
5 out of 5 stars
-
Very very inspirational to me.
- By Fábio on 06-12-17
By: Charles A. O'Reilly III, and others
-
Born to Build
- How to Build a Thriving Startup, a Winning Team, New Customers and Your Best Life Imaginable
- By: Jim Clifton, Sangeeta Badal
- Narrated by: Braden Wright
- Length: 3 hrs and 47 mins
- Unabridged
-
Overall4.5 out of 5 stars 77
-
Performance4.5 out of 5 stars 68
-
Story4 out of 5 stars 68
Written for anyone trying to figure out how to make the most of their lives, Born to Build seeks to inspire entrepreneurs and ambitious, self-motivated people to build something that will change the world. A builder’s venture could be a small business that grows into a mammoth enterprise, a thriving new division in an existing company, a nonprofit, a social enterprise, a church, a school - anything that creates economic growth and makes a lasting impact on society.
-
5 out of 5 stars
-
Powerful perspective shift
- By Diana_loves_audiobooks on 06-09-18
By: Jim Clifton, and others
-
Engine of Impact
- Essentials of Strategic Leadership in the Nonprofit Sector
- By: William F. Meehan III, Kim Starkey Jonker
- Narrated by: C. J. Lengua
- Length: 7 hrs and 32 mins
- Unabridged
-
Overall4.5 out of 5 stars 45
-
Performance4.5 out of 5 stars 37
-
Story4 out of 5 stars 37
We are entering a new era - an era of impact. The largest intergenerational transfer of wealth in history will soon be underway, bringing with it the potential for huge increases in philanthropic funding. Engine of Impact shows how nonprofits can apply the principles of strategic leadership to attract greater financial support and leverage that funding to maximum effect.
-
4 out of 5 stars
-
Must listen for all nonprofit leaders
- By Peter A. Mello on 02-09-19
By: William F. Meehan III, and others
-
Machine, Platform, Crowd
- Harnessing Our Digital Future
- By: Erik Brynjolfsson, Andrew McAfee
- Narrated by: Jeff Cummings
- Length: 10 hrs and 57 mins
- Unabridged
-
Overall4.5 out of 5 stars 1,195
-
Performance4.5 out of 5 stars 1,002
-
Story4.5 out of 5 stars 997
In The Second Machine Age, Andrew McAfee and Erik Brynjolfsson predicted some of the far-reaching effects of digital technologies on our lives and businesses. Now they’ve written a guide to help listeners make the most of our collective future. Machine | Platform | Crowd outlines the opportunities and challenges inherent in the science fiction technologies that have come to life in recent years, like self-driving cars and 3D printers, online platforms for renting outfits and scheduling workouts, or crowd-sourced medical research and financial instruments.
-
5 out of 5 stars
-
Both How AND Why for Techies
- By Dan Collins on 08-11-17
By: Erik Brynjolfsson, and others
-
Economics for the Common Good
- By: Jean Tirole, Steven Rendell - translator
- Narrated by: Jonathan Davis
- Length: 18 hrs and 54 mins
- Unabridged
-
Overall4.5 out of 5 stars 55
-
Performance4.5 out of 5 stars 43
-
Story4.5 out of 5 stars 41
When Jean Tirole won the 2014 Nobel Prize in Economics, he suddenly found himself being stopped in the street by complete strangers and asked to comment on issues of the day, no matter how distant from his own areas of research. His transformation from academic economist to public intellectual prompted him to reflect further on the role economists and their discipline play in society. The result is Economics for the Common Good, a passionate manifesto for a world in which economics, far from being a "dismal science," is a positive force for the common good.
-
4 out of 5 stars
-
A Great Overview of the Challenges of Modern Econ
- By Zach Sullivan on 08-06-18
By: Jean Tirole, and others
-
Power and Prediction
- The Disruptive Economics of Artificial Intelligence
- By: Ajay Agrawal, Joshua Gans, Avi Goldfarb
- Narrated by: Tom Beyer
- Length: 10 hrs and 7 mins
- Unabridged
-
Overall4.5 out of 5 stars 80
-
Performance4.5 out of 5 stars 71
-
Story4.5 out of 5 stars 71
In their bestselling first book, Prediction Machines, eminent economists Ajay Agrawal, Joshua Gans, and Avi Goldfarb explained the simple yet game-changing economics of AI. Now, in Power and Prediction, they go deeper, examining the most basic unit of analysis: the decision. The authors explain that the two key decision-making ingredients are prediction and judgment, and we perform both together in our minds, often without realizing it.
-
5 out of 5 stars
-
Inspire system thinking with informative examples
- By Lucy A. Pithecus on 11-16-22
By: Ajay Agrawal, and others
-
Competition Demystified
- A Radically Simplified Approach to Business Strategy
- By: Judd Kahn, Bruce C. Greenwald
- Narrated by: Timothy Andrés Pabon
- Length: 14 hrs and 22 mins
- Unabridged
-
Overall4.5 out of 5 stars 49
-
Performance4.5 out of 5 stars 40
-
Story4.5 out of 5 stars 39
Bruce Greenwald, one of the nation's leading business professors, presents a new and simplified approach to strategy that cuts through much of the fog that has surrounded the subject. Based on his hugely popular course at Columbia Business School, Greenwald and his co-author, Judd Kahn, offer an easy-to-follow method for understanding the competitive structure of your industry and developing an appropriate strategy for your specific position.
-
3 out of 5 stars
-
Prof, we need the figures/graphs that’s in the the book
- By sid on 12-25-20
By: Judd Kahn, and others
-
Blind Spots
- Why We Fail to Do What’s Right and What to Do about It
- By: Max H. Bazerman, Ann E. Tenbrunsel
- Narrated by: Kate McQueen
- Length: 7 hrs and 18 mins
- Unabridged
-
Overall4 out of 5 stars 98
-
Performance4 out of 5 stars 79
-
Story4 out of 5 stars 80
When confronted with an ethical dilemma, most of us like to think we would stand up for our principles. But we are not as ethical as we think we are. In Blind Spots, leading business ethicists Max Bazerman and Ann Tenbrunsel examine the ways we overestimate our ability to do what is right and how we act unethically without meaning to.
-
4 out of 5 stars
-
Great book
- By Ryan in SF on 11-15-18
By: Max H. Bazerman, and others
People who viewed this also viewed...
-
The Billion Dollar Molecule
- One Company's Quest for the Perfect Drug
- By: Barry Werth
- Narrated by: Stephen Bowlby
- Length: 18 hrs and 25 mins
- Unabridged
-
Overall4.5 out of 5 stars 24
-
Performance4 out of 5 stars 20
-
Story4 out of 5 stars 20
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.
-
4 out of 5 stars
-
Book is interesting but narrator is not
- By Anonymous User on 05-05-23
By: Barry Werth
-
For Blood and Money
- Billionaires, Biotech, and the Quest for a Blockbuster Drug
- By: Nathan Vardi
- Narrated by: Rob Shapiro
- Length: 8 hrs and 33 mins
- Unabridged
-
Overall4.5 out of 5 stars 184
-
Performance4.5 out of 5 stars 155
-
Story4.5 out of 5 stars 154
For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug and how the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.
-
5 out of 5 stars
-
Must-read for biotech enthusiasts and scientists
- By Anonymous User on 03-16-23
By: Nathan Vardi
-
Genentech
- The Beginnings of Biotech
- By: Sally Smith Hughes
- Narrated by: Suzie Althens
- Length: 7 hrs and 12 mins
- Unabridged
-
Overall4 out of 5 stars 32
-
Performance4 out of 5 stars 25
-
Story4.5 out of 5 stars 25
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.
-
2 out of 5 stars
-
Shallow and lifeless
- By LTS on 11-26-23
-
The Comprehensive Guide to Clinical Research
- A Practical Handbook for Gaining Insight into the Clinical Research Industry
- By: Dan Sfera, Chris Sauber
- Narrated by: Dan Sfera, Chris Sauber
- Length: 10 hrs and 17 mins
- Unabridged
-
Overall4.5 out of 5 stars 83
-
Performance4.5 out of 5 stars 65
-
Story4.5 out of 5 stars 63
Condensing the most important topics in all of clinical research in an easy-to-understand presentation. The 20 percent of what you need to know in order to be 80 percent proficient! The authors who have operated various levels of businesses in the clinical research industry since 2005 believe that more practical information pertaining to clinical research needs to be accessible to individuals who are new to the industry or are curious about entering the rewarding world of clinical trials.
-
2 out of 5 stars
-
Good idea poorly executed
- By Dino D on 03-02-20
By: Dan Sfera, and others
-
The Drug Discovery and Development Cycle
- A Concise Overview of the Key Steps from Concept to Launch
- By: Kabir Hussain
- Narrated by: Rebecca Sharp
- Length: 1 hr and 31 mins
- Unabridged
-
Overall4.5 out of 5 stars 16
-
Performance5 out of 5 stars 12
-
Story4.5 out of 5 stars 11
The pharmaceutical drug discovery and development cycle is long and complex. This audiobook provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development.
By: Kabir Hussain
-
Inside the Orphan Drug Revolution
- The Promise of Patient-Centered Biotechnology
- By: James A. Geraghty
- Narrated by: Scott Wallace
- Length: 7 hrs and 39 mins
- Unabridged
-
Overall4.5 out of 5 stars 5
-
Performance5 out of 5 stars 4
-
Story5 out of 5 stars 4
Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception―a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. His book is in part a history, with eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. And it tells deeply personal stories of patients and parents willing to risk untried new therapies.
-
5 out of 5 stars
-
powerful and insightful
- By Colin G. on 06-01-23
-
The Billion Dollar Molecule
- One Company's Quest for the Perfect Drug
- By: Barry Werth
- Narrated by: Stephen Bowlby
- Length: 18 hrs and 25 mins
- Unabridged
-
Overall4.5 out of 5 stars 24
-
Performance4 out of 5 stars 20
-
Story4 out of 5 stars 20
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.
-
4 out of 5 stars
-
Book is interesting but narrator is not
- By Anonymous User on 05-05-23
By: Barry Werth
-
For Blood and Money
- Billionaires, Biotech, and the Quest for a Blockbuster Drug
- By: Nathan Vardi
- Narrated by: Rob Shapiro
- Length: 8 hrs and 33 mins
- Unabridged
-
Overall4.5 out of 5 stars 184
-
Performance4.5 out of 5 stars 155
-
Story4.5 out of 5 stars 154
For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug and how the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.
-
5 out of 5 stars
-
Must-read for biotech enthusiasts and scientists
- By Anonymous User on 03-16-23
By: Nathan Vardi
-
Genentech
- The Beginnings of Biotech
- By: Sally Smith Hughes
- Narrated by: Suzie Althens
- Length: 7 hrs and 12 mins
- Unabridged
-
Overall4 out of 5 stars 32
-
Performance4 out of 5 stars 25
-
Story4.5 out of 5 stars 25
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.
-
2 out of 5 stars
-
Shallow and lifeless
- By LTS on 11-26-23
-
The Comprehensive Guide to Clinical Research
- A Practical Handbook for Gaining Insight into the Clinical Research Industry
- By: Dan Sfera, Chris Sauber
- Narrated by: Dan Sfera, Chris Sauber
- Length: 10 hrs and 17 mins
- Unabridged
-
Overall4.5 out of 5 stars 83
-
Performance4.5 out of 5 stars 65
-
Story4.5 out of 5 stars 63
Condensing the most important topics in all of clinical research in an easy-to-understand presentation. The 20 percent of what you need to know in order to be 80 percent proficient! The authors who have operated various levels of businesses in the clinical research industry since 2005 believe that more practical information pertaining to clinical research needs to be accessible to individuals who are new to the industry or are curious about entering the rewarding world of clinical trials.
-
2 out of 5 stars
-
Good idea poorly executed
- By Dino D on 03-02-20
By: Dan Sfera, and others
-
The Drug Discovery and Development Cycle
- A Concise Overview of the Key Steps from Concept to Launch
- By: Kabir Hussain
- Narrated by: Rebecca Sharp
- Length: 1 hr and 31 mins
- Unabridged
-
Overall4.5 out of 5 stars 16
-
Performance5 out of 5 stars 12
-
Story4.5 out of 5 stars 11
The pharmaceutical drug discovery and development cycle is long and complex. This audiobook provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development.
By: Kabir Hussain
-
Inside the Orphan Drug Revolution
- The Promise of Patient-Centered Biotechnology
- By: James A. Geraghty
- Narrated by: Scott Wallace
- Length: 7 hrs and 39 mins
- Unabridged
-
Overall4.5 out of 5 stars 5
-
Performance5 out of 5 stars 4
-
Story5 out of 5 stars 4
Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception―a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. His book is in part a history, with eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. And it tells deeply personal stories of patients and parents willing to risk untried new therapies.
-
5 out of 5 stars
-
powerful and insightful
- By Colin G. on 06-01-23
-
Immune
- A Journey into the Mysterious System That Keeps You Alive
- By: Philipp Dettmer
- Narrated by: Steve Taylor
- Length: 10 hrs and 28 mins
- Unabridged
-
Overall5 out of 5 stars 1,175
-
Performance5 out of 5 stars 1,008
-
Story5 out of 5 stars 1,001
You wake up and feel a tickle in your throat. Your head hurts. You’re mildly annoyed as you get the kids ready for school and dress for work yourself. Meanwhile, an epic war is being fought, just below your skin. Millions are fighting and dying for you to be able to complain as you head out the door. So what, exactly, is your immune system? In Immune, Philipp Dettmer, the brains behind the most popular science channel on YouTube, takes listeners on a journey through the fortress of the human body and its defenses.
-
5 out of 5 stars
-
Steve Taylor for the win
- By Bay Area Engineer on 11-02-21
By: Philipp Dettmer
-
The AI Revolution in Medicine
- GPT-4 and Beyond
- By: Peter Lee, Carey Goldberg, Isaac Kohane
- Narrated by: J. Hunter Ackerman
- Length: 7 hrs and 24 mins
- Unabridged
-
Overall4.5 out of 5 stars 26
-
Performance4.5 out of 5 stars 22
-
Story4.5 out of 5 stars 22
Just months ago, millions of people were stunned by ChatGPT's amazing abilities–and its bizarre hallucinations. But that was 2022. GPT-4 is now here, with smarter, more accurate, and deeper technical knowledge. GPT-4 and its competitors and followers are on the verge of transforming medicine. But with lives on the line, you need to understand these technologies–stat.
-
2 out of 5 stars
-
Self-Serving Junk
- By Memphis Matt on 09-11-23
By: Peter Lee, and others
-
The Antidote
- Inside the World of New Pharma
- By: Barry Werth
- Narrated by: Sean Pratt
- Length: 16 hrs and 27 mins
- Unabridged
-
Overall4 out of 5 stars 75
-
Performance4 out of 5 stars 64
-
Story4 out of 5 stars 65
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex's bold endurance and eventual success.
-
2 out of 5 stars
-
For me this was not interesting
- By Yan on 06-26-17
By: Barry Werth
-
Deep Medicine
- How Artificial Intelligence Can Make Healthcare Human Again
- By: Eric Topol
- Narrated by: Graham Winton
- Length: 11 hrs and 6 mins
- Unabridged
-
Overall4.5 out of 5 stars 743
-
Performance4.5 out of 5 stars 626
-
Story4.5 out of 5 stars 622
Medicine has become inhuman, to disastrous effect. The doctor-patient relationship - the heart of medicine - is broken: doctors are too distracted and overwhelmed to truly connect with their patients, and medical errors and misdiagnoses abound. In Deep Medicine, leading physician Eric Topol reveals how artificial intelligence can help. AI has the potential to transform everything doctors do, from notetaking and medical scans to diagnosis and treatment, greatly cutting down the cost of medicine and reducing human mortality.
-
5 out of 5 stars
-
a must book for all doctors and patients.
- By adva onn on 04-21-19
By: Eric Topol
-
The Great American Drug Deal
- A New Prescription for Innovative and Affordable Medicines
- By: Peter Kolchinsky
- Narrated by: Sean Pratt
- Length: 8 hrs and 27 mins
- Unabridged
-
Overall4.5 out of 5 stars 32
-
Performance4.5 out of 5 stars 24
-
Story4.5 out of 5 stars 24
Developing life-changing drugs is risky and expensive, but that’s not what makes them unaffordable. Drug pricing is a staple of every news cycle and political debate. And while we’ve struggled for decades to agree on solutions that serve all patients without jeopardizing the invention of new medicines, many Americans suffer because they can’t afford the drugs they need. Do we really have to choose between affordability and innovation?
By: Peter Kolchinsky
-
The Founder's Dilemmas
- By: Noam Wasserman
- Narrated by: Mark Mosely
- Length: 13 hrs and 28 mins
- Unabridged
-
Overall4.5 out of 5 stars 721
-
Performance4.5 out of 5 stars 579
-
Story4 out of 5 stars 571
Often downplayed in the excitement of starting up a new business venture is one of the most important decisions entrepreneurs will face: should they go it alone, or bring in cofounders, hires, and investors to help build the business? More than just financial rewards are at stake. Friendships and relationships can suffer. Bad decisions at the inception of a promising venture lay the foundations for its eventual ruin.
-
2 out of 5 stars
-
Too much talk on the data
- By Stanley Tan on 10-02-14
By: Noam Wasserman
-
The Song of the Cell
- An Exploration of Medicine and the New Human
- By: Siddhartha Mukherjee
- Narrated by: Dennis Boutsikaris
- Length: 16 hrs and 3 mins
- Unabridged
-
Overall4.5 out of 5 stars 777
-
Performance5 out of 5 stars 659
-
Story4.5 out of 5 stars 653
From the author of The Emperor of All Maladies, winner of the Pulitzer Prize, and The Gene, a #1 New York Times bestseller, comes his most spectacular book yet, an exploration of medicine and our radical new ability to manipulate cells. Rich with Mukherjee’s revelatory and exhilarating stories of scientists, doctors, and the patients whose lives may be saved by their work, The Song of the Cell is the third book in this extraordinary writer’s exploration of what it means to be human.
-
5 out of 5 stars
-
Beyond Words Wonderful
- By Lynn on 11-27-22
-
Bottle of Lies
- The Inside Story of the Generic Drug Boom
- By: Katherine Eban
- Narrated by: Katherine Eban
- Length: 14 hrs and 26 mins
- Unabridged
-
Overall5 out of 5 stars 1,054
-
Performance4.5 out of 5 stars 924
-
Story5 out of 5 stars 922
From an award-winning Fortune reporter, an explosive narrative investigation of the generic drug boom that reveals the life-threatening dangers posed by globalization - The Jungle for pharmaceuticals.
-
1 out of 5 stars
-
overbearing self-righteous indignation
- By VB on 01-13-20
By: Katherine Eban
-
Fundamentals of Clinical Trials
- By: Lawrence M. Friedman, Curt D. Furberg, David L. DeMets
- Narrated by: Douglas Martin
- Length: 3 hrs and 56 mins
- Abridged
-
Overall5 out of 5 stars 5
-
Performance5 out of 5 stars 4
-
Story5 out of 5 stars 4
This book is intended for the clinical researcher who is interested in designing a clinical trial and developing a protocol. It is also of value to researchers and practitioners who must critically evaluate the literature of published clinical trials and assess the merits of each trial and the implications for the care and treatment of patients. The authors use numerous examples of published clinical trials to illustrate the fundamentals.
-
5 out of 5 stars
-
A great overview in just 4 hours!
- By M. Buzard on 04-30-23
By: Lawrence M. Friedman, and others
-
Ten Drugs
- How Plants, Powders, and Pills Have Shaped the History of Medicine
- By: Thomas Hager
- Narrated by: Angelo Di Loreto
- Length: 8 hrs and 39 mins
- Unabridged
-
Overall4.5 out of 5 stars 4,852
-
Performance4.5 out of 5 stars 4,199
-
Story4.5 out of 5 stars 4,181
Beginning with opium, the “joy plant,” which has been used for 10,000 years, Thomas Hager tells a captivating story of medicine. His subjects include the largely forgotten female pioneer who introduced smallpox inoculation to Britain, the infamous knockout drops, the first antibiotic, which saved countless lives, the first antipsychotic, which helped empty public mental hospitals, Viagra, statins, and the new frontier of monoclonal antibodies. This is a deep, wide-ranging, and wildly entertaining book.
-
4 out of 5 stars
-
Engrossing to physicians & lay persons alike
- By C. White on 03-08-19
By: Thomas Hager
-
The Code Breaker
- Jennifer Doudna, Gene Editing, and the Future of the Human Race
- By: Walter Isaacson
- Narrated by: Kathe Mazur, Walter Isaacson
- Length: 16 hrs and 4 mins
- Unabridged
-
Overall4.5 out of 5 stars 6,190
-
Performance4.5 out of 5 stars 5,250
-
Story4.5 out of 5 stars 5,217
The bestselling author of Leonardo da Vinci and Steve Jobs returns with a “compelling” (The Washington Post) account of how Nobel Prize winner Jennifer Doudna and her colleagues launched a revolution that will allow us to cure diseases, fend off viruses, and have healthier babies.
-
4 out of 5 stars
-
Except for the author, this book is good!
- By Johan on 03-14-21
By: Walter Isaacson
-
The Molecule of More
- How a Single Chemical in Your Brain Drives Love, Sex, and Creativity - And Will Determine the Fate of the Human Race
- By: Daniel Z. Lieberman MD, Michael E. Long
- Narrated by: Tom Parks
- Length: 8 hrs and 13 mins
- Unabridged
-
Overall4.5 out of 5 stars 2,617
-
Performance4.5 out of 5 stars 2,208
-
Story4.5 out of 5 stars 2,188
In The Molecule of More: How a Single Chemical in Your Brain Drives Love, Sex, and Creativity—and will Determine the Fate of the Human Race, George Washington University professor and psychiatrist Daniel Z. Lieberman, MD, and Georgetown University lecturer Michael E. Long present a potentially life-changing proposal: Much of human life has an unconsidered component that explains an array of behaviors previously thought to be unrelated, including why winners cheat, why geniuses often suffer with mental illness, why nearly all diets fail, and more.
-
3 out of 5 stars
-
Did you know conservatives have more orgasms?
- By Josh on 10-21-20
By: Daniel Z. Lieberman MD, and others
What listeners say about From Breakthrough to Blockbuster
Average customer ratingsReviews - Please select the tabs below to change the source of reviews.
-
Overall5 out of 5 stars
-
Performance5 out of 5 stars
-
Story5 out of 5 stars
- Momo Abbasi
- 04-28-24
Wonderful book!
If you want to understand the biotech industry you MUST READ this! Comprehensive and easy to follow.
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!
-
Overall5 out of 5 stars
-
Performance5 out of 5 stars
-
Story5 out of 5 stars
- Fox2
- 11-12-22
Excellent description of the biotech industry
Fantastic book describing the biotech industry from its beginning to now. Engaging and recommended to read or listen.
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!
-
Overall2 out of 5 stars
-
Performance3 out of 5 stars
-
Story2 out of 5 stars
- Anonymous User
- 09-12-23
Nothing to learn for pharma professionals
Nice introduction to the world of pharma R&D, but those who’ve been in the business have probably heard the stories many times already.
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!